US To Weigh Authorizing Pfizer Covid Vaccine For Younger Children
Muhammad Irfan Published October 26, 2021 | 12:59 PM
A high-level medical panel of US government advisors will meet Tuesday to decide whether to authorize the Pfizer Covid-19 vaccine for children aged five to 11 years old
Washington, (UrduPoint / Pakistan Point News - 26th Oct, 2021 ) :A high-level medical panel of US government advisors will meet Tuesday to decide whether to authorize the Pfizer Covid-19 vaccine for children aged five to 11 years old.
If, as is widely expected, the independent experts convened by the food and Drug Administration (FDA) vote in favor, an emergency authorization could follow within weeks.
This would make 28 million younger children eligible for the shots in November.
The question before the panel: based on the scientific evidence available, do the benefits of the two-dose vaccine, given three weeks apart, outweigh the known risks? Ahead of the meeting, the FDA uploaded an analysis by Pfizer that showed the vaccine -- given at 10 micrograms instead of 30 micrograms as in older groups -- was 90.7 percent effective at preventing symptomatic Covid-19, and there were no serious safety issues.
The FDA also posted its own briefing document containing a risk-benefit analysis, which indicated the agency's scientists believe the benefits exceed the most worrying potential side-effect for this age group: myocarditis, or heart inflammation.
"My initial thought is that the benefits of vaccinating children five through 11 years outweigh the risks of myocarditis and other safety concerns that people may have," Henry Bernstein, a pediatrician at Cohen Children's Medical Center in New York, told AFP.
Overall, 160 children aged five to 11 have died from Covid-19 in the United States since the start of the pandemic, according to official data -- a tiny fraction of the total of more than 730,000.
But millions have been infected and thousands hospitalized. There have also been more than 5,000 cases of multisystem inflammatory syndrome in children (MIS-C), a rare but highly serious post-viral complication, which has claimed 46 lives.
"Of course, (we) want to protect the children, but we also want them to not be transmitting SARS-CoV-2 virus to family members and other people in the community," said Bernstein.
- Myocarditis rate likely low - Pfizer evaluated safety data from a total of 3,000 vaccinated participants, with the most common side-effects mild or moderate, including injection site pain, fatigue, headache, muscle pain and chills.
There were no cases of myocarditis or pericarditis (inflammation around the heart), but the company said there were not enough study volunteers to be able to detect highly rare side-effects.
Very rare instances of myocarditis were only detected in adolescents after the vaccine was authorized in June and given to millions of people in that age group, rather than the thousands that were tested in trials.
Scientists believe it will be even rarer among younger children, but don't expect to know just how rare until it is green-lighted.
The FDA acknowledged that, hypothetically speaking, if Covid-19 transmission was crushed within communities -- as was the case last in June 2021 -- the number of vaccine-induced myocarditis cases could exceed the number of Covid-19 hospitalizations prevented.
But even then, it added, the benefits might still exceed the risks, because non-hospitalized Covid-19 cases can have more serious consequences than side-effects, which are normally temporary.
The United States is emerging from its latest wave driven by the Delta variant.
But cases remain high in northern states such as Alaska, Montana, Wyoming and Idaho, which are experiencing colder weather and have lagging vaccination rates.
Overall, 57 percent of the total population is now fully vaccinated.
Vaccine confidence has risen in recent months, but the United States remains behind every other G7 nation in percent of population fully vaccinated.
Related Topics
Recent Stories
PM calls for joint efforts to check smuggling, power theft
Infinix Unveils a Vibrant New Chapter with Wahaj Ali: The face of Infinix NOTE 4 ..
PM makes two more appointments in his team
Terrorists of Shangla suicide attack will be brought to justice: Interior Minist ..
Applications Open for 6th Cycle of Start-up Incubation under the National Expans ..
Join vivo's "Light it Up" Social Media Contest in Ramadan to Win vivo V30 5G
Pakistan v New Zealand T20I series: Tickets to go on sale from today
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 29 March 2024
Today Gold Rate in Pakistan 29 March 2024
Journalists call for global action to end Gaza’s humanitarian crisis
CM for generating opportunities to bring direct int'l investment
Pakistan retains position in FTSE secondary emerging market
More Stories From Health
-
Increased diagnostic testing for drug resistance
6 days ago -
IRD releases groundbreaking results of end TB programme
8 days ago -
Increased diagnostic testing for drug resistance TB will enhance patients’ treatment outcome
11 days ago -
JRF to provide insulin to underprivileged diabetic patients
13 days ago -
MBBS third professional annual exams 2023: check results here
14 days ago -
CM Maryam visits PIC, inquiries after patients
16 days ago
-
Health expert recommends exercise for weight loss in Ramazan
18 days ago -
Blood camp held at SNGPL office
18 days ago -
Free Medical camp for people with mental, physical disabilities
24 days ago -
Breast cancer has become most common disease in few years: expert
24 days ago -
Punjab Healthcare Commission shuts down 634 illegal treatment centers
24 days ago -
COMSTECH, Al-Shifa Trust team conduct free cataract eye surgeries in Somalia
24 days ago